A look at Werewolf Therapeutics Inc’s (HOWL) recent performance gives investors their first glimpse of hope.

Werewolf Therapeutics Inc (NASDAQ: HOWL) on Tuesday, soared 13.33% from the previous trading day, before settling in for the closing price of $1.20. Within the past 52 weeks, HOWL’s price has moved between $0.60 and $4.73.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company achieved an average annual earnings per share of -6.03%. With a float of $33.12 million, this company’s outstanding shares have now reached $44.83 million.

The firm has a total of 46 workers. Let’s measure their productivity. In terms of profitability, gross margin is 60.28%, operating margin of -4937.18%, and the pretax margin is -6335.17%.

Werewolf Therapeutics Inc (HOWL) Insider Activity

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Werewolf Therapeutics Inc is 26.20%, while institutional ownership is 47.57%. The most recent insider transaction that took place on May 12 ’25, was worth 275,985. In this transaction Director of this company bought 320,913 shares at a rate of $0.86, taking the stock ownership to the 6,021,969 shares. Before that another transaction happened on May 14 ’25, when Company’s Director bought 162,539 for $0.98, making the entire transaction worth $159,288. This insider now owns 6,237,482 shares in total.

Werewolf Therapeutics Inc (HOWL) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around -6.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.48% during the next five years compared to -20.76% drop over the previous five years of trading.

Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators

Werewolf Therapeutics Inc (HOWL) is currently performing well based on its current performance indicators. A quick ratio of 8.09 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 53.54.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -1.56 in one year’s time.

Technical Analysis of Werewolf Therapeutics Inc (HOWL)

Analysing the last 5-days average volume posted by the [Werewolf Therapeutics Inc, HOWL], we can find that recorded value of 0.51 million was better than the volume posted last year of 0.34 million. As of the previous 9 days, the stock’s Stochastic %D was 73.16%. Additionally, its Average True Range was 0.11.

During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 75.28%, which indicates a significant decrease from 93.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.87% in the past 14 days, which was lower than the 92.04% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.9556, while its 200-day Moving Average is $1.6007. Now, the first resistance to watch is $1.4333. This is followed by the second major resistance level at $1.5067. The third major resistance level sits at $1.6233. If the price goes on to break the first support level at $1.2433, it is likely to go to the next support level at $1.1267. Should the price break the second support level, the third support level stands at $1.0533.

Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats

Market capitalization of the company is 61.03 million based on 44,874K outstanding shares. Right now, sales total 1,890 K and income totals -70,520 K. The company made 0 K in profit during its latest quarter, and -18,090 K in sales during its previous quarter.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.